Extensive cancer screening may not improve outcomes for patients with unprovoked venous thromboembolism
1. Although more extensive screening may detect more cases of occult cancer in patients with unprovoked venous thromboembolism (VTE) at ...
Tag: venous thromboembolism
![Adverse pregnancy outcomes associated with thrombophilias [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2015/07/Classics-2-Minute-Medicine-e1436017941513-350x250.png)
The SOME trial: Screening for occult malignancy in unprovoked venous thromboembolism [Classics Series]
1. Patients with a first unprovoked venous thromboembolism were randomized to either limited-screening for occult malignancy or limited-screening plus computed ...
Splanchnic vein thrombosis associated with high risk of bleeding and recurrent thrombosis
1. Amongst a multi-center, international cohort of patients diagnosed with splanchnic vein thrombosis (SVT), the risk of recurrent thrombotic events, ...
Heparin bridging may increase bleeding without preventing recurrent thromboembolism
1. Patients who underwent bridging therapy with heparin during warfarin interruption for procedures had a significantly higher risk of bleed ...
2 Minute Medicine Rewind January 12, 2015 – January 19, 2015
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Factor ...
Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery
1. A factor XI anti-sense oligonucleotide, FXI-ASO, was associated with lower incidence of venous thromboembolism compared with enoxaparin in patients ...
2 Minute Medicine Rewind November 3 – November 9, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Cost-Effectiveness ...
2 Minute Medicine Rewind October 26 – November 2, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Clinical ...
No benefit in prolonged anticoagulation in cancer patients without residual venous thrombosis
1. Cancer patients treated with 6 months of low molecular weight heparin (LMWH) for first-time DVT with no residual clot do ...
2 Minute Medicine Rewind September 14 – September 21, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Ultrasonography ...
